I-MAB

-$0.95 (-1.42%) Today
+$1.77 (+2.69%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell I-MAB and other ETFs, options, and stocks.

About IMAB

I-Mab operates as a clinical stage biopharmaceutical company. It engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders.

CEO
Hua Qiong Shen
Employees
228
Headquarters
Pudong, Shanghai
Founded
2016

IMAB Key Statistics

Market Cap
5.07B
Price-Earnings Ratio
56.13
Dividend Yield
Average Volume
506.39K
High Today
$68.18
Low Today
$65.72
Open Price
$67.12
Volume
165.51K
52 Week High
$85.40
52 Week Low
$32.64

IMAB Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Available Aug 31, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure